ArticleCancer management and research2019

Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study.

Zhiwei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.